HENNEPIN HEALTHCARE RESEARCH INSTITUTE
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa
Clinical and immunologic factors underlying heart failure with preserved ejection fraction among persons with HIV in South Africa is a funding opportunity from HENNEPIN HEALTHCARE RESEARCH INSTITUTE, up to 513760, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Premise: HIV associated CVD is a significant cause of clinical morbidity and a barrier to successful aging among persons living with HIV (PWH). To date, HIV-CVD research has emphasized ischemic coronary heart disease. However, nearly 80% of the global CVD burden exists in developing nations and 70% of the HIV epidemic…